Ginkgo Bioworks Holdings, Inc. (DNA) stock surged +11.21%, trading at $14.29 on NYSE, up from the previous close of $12.85. The stock opened at $13.29, fluctuating between $12.96 and $14.37 in the recent session.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Employees | 1218 |
Beta | 1.1 |
Sales or Revenue | $251.46M |
5Y Sales Change% | 140.776% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stock price is $14.29 in the last trading session. During the trading session, DNA stock reached the peak price of $14.37 while $12.96 was the lowest point it dropped to. The percentage change in DNA stock occurred in the recent session was 11.21% while the dollar amount for the price change in DNA stock was $1.44.
The NYSE listed DNA is part of Biotechnology industry that operates in the broader Healthcare sector. Ginkgo Bioworks Holdings, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Steven P. Coen C.P.A.
Chief Accounting Officer
Marie E Fallon
Chief Accounting Officer
Mr. Austin Che
Founder, Head of Strategy & Treasurer
Mr. Bartholomew Canton
Founder, Chief Technology Officer & Sec.
Mr. Steven P. Coen CPA
Chief Accounting Officer
Karen Tepichin
Gen. Counsel & Sec.
Ms. Anna Marie Wagner
Senior Vice President of Corporation Devel.
Ms. Samantha Sutton
Head of People
Ms. Marie E Fallon
Chief Accounting Officer
Dr. Jason Kelly
Founder, Chief Executive Officer & Director
Dr. Reshma P. Shetty
Founder, Pres, Chief Operating Officer & Director
Mr. Mark E. Dmytruk
Chief Financial Officer
Mr. Thomas Knight Jr.
Founder
DNA's closing price is 171.67% higher than its 52-week low of $5.26 where as its distance from 52-week high of $64.40 is -77.81%.
Number of DNA employees currently stands at 1,218.
Official Website of DNA is: https://www.ginkgobioworks.com
DNA could be contacted at phone 877 422 5362 and can also be accessed through its website. DNA operates from 27 Drydock Avenue, Boston, MA 02210, United States.
DNA stock volume for the day was 1.48M shares. The average number of DNA shares traded daily for last 3 months was 1.4M.
The market value of DNA currently stands at $821.37M with its latest stock price at $14.29 and 57.48M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com